Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Time to treatment augmentation was measured as the duration from day 60 to the date of adding a new glucose-lowering drug class that was neither the index drug class nor the treatment used at baseline
The discontinuation is not related to any safety concern with liraglutide
In recent years, medical weight loss programs have grown in popularity as an option for people struggling with obesity
German J, Cordioli M, Tozzo V, Urbut S, Arumae K, Smit RAJ, et al
US$ 28.77
US$ 24.93
US$ 20.20
US$ 27.63
